- Recall of one lot of Moderna COVID-19 vaccines due to a foreign body.
- High raw material prices for heparin production due to African swine fever in China.
- Customer concentration risk due to collaboration with Moderna.
Laboratorios Farmacéuticos Rovi, S.A.
Greenhouse gas emissions & sustainability report data
In its 2022 reporting, Laboratorios Farmacéuticos Rovi, S.A. disclosed greenhouse gas emissions of 7.3K tCO2e (Scope 1 & 2) + 659 tCO2e (Scope 3). Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
7.3K tCO2e (Scope 1 & 2) + 659 tCO2e (Scope 3)
2022
Renewable Energy
100% (electricity)
of total energy
Water Usage
182.2K m3
2022
Waste
6.4K tons
2022
Energy Use
14.3M kWh
2022
📈 Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2022 | 7.3K tCO2e (Scope 1 & 2) + 659 tCO2e (Scope 3) |
| 2021 | 6.2K tonnes CO2e (Scopes 1 & 2) |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.
✅ Reported Environmental Achievements
- Achieved carbon neutrality for Scopes 1 and 2 for the third consecutive year.
- Contracted 100% renewable energy for all manufacturing plants and main offices.
- Installed photovoltaic panels at Alcalá de Henares and Granada plants, generating renewable energy.
🎯 Climate & Sustainability Targets
🔜 Short-term
- Maintain service levels in responding to customer claims.
- Implement a system to digitalize human capital management.
- Develop and implement a new performance evaluation system.
📅 Medium-term
- Achieve climate neutrality.
- Integrate circularity into activities and waste management.
- Promote sustainable water management.
🌱 ESG Focus Areas
GovernanceSocialEnvironmental